ALBIREO PHARMA, INC. Annual Income Tax Expense (Benefit) in USD from 2010 to 2018

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Albireo Pharma, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2018.
  • Albireo Pharma, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2022 was $0.000, a 100% decline year-over-year.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2018 was $20K, a 90.6% decline from 2017.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2017 was $212K, a 242% increase from 2016.
  • Albireo Pharma, Inc. annual Income Tax Expense (Benefit) for 2016 was $62K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.